Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps

被引:8
作者
Escobar, P
Márquez, FJ
Carrasco, C
Alonso-Orgaz, S
Fortes, J
Cenjor, C
López-Farré, A
机构
[1] Hosp Clin San Carlos, Cardiovasc Inst, Madrid 28040, Spain
[2] Fdn Jimenez Diaz, Dept Otorhinolaryngol, E-28040 Madrid, Spain
关键词
cyclic GMP; endothelium; guanylate cyclase; nitric oxide; nasal mucosa; polyps;
D O I
10.1007/s00405-004-0857-2
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The aim of our study was to analyze the level of expression of the endothelial nitric oxide synthase (eNOS)/soluble guanylate cyclase (sGC) system in nasal polyps and control nasal mucosae. The study was performed in polyps from 15 patients and nasal mucosae from 11 subjects operated on the nasal septum (control group). The expression of endothelial nitric oxide synthase (eNOS) and soluble guanylate cyclase (sGC) was determined in nasal mucosae. Western blot analysis demonstrated that eNOS protein was overexpressed in the nasal polyps with respect to control nasal mucosae. Immunohistochemistry also demonstrated that the vascular endothelium of nasal polyps contained higher amounts of eNOS protein than control nasal mucosae. Moreover, the beta(1) subunit of sGC was also overexpressed in the nasal polyps, which was associated with an increased content of cyclic GMP in the nasal polyps with respect to nasal control mucosae. In human nasal polyposis, there is an overexpression of the eNOS/sGC system. Further studies are needed to assess whether this overexpression is involved in the genesis of nasal polyposis.
引用
收藏
页码:512 / 516
页数:5
相关论文
共 50 条
[1]   Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps [J].
Paloma Escobar ;
Francisco J Márquez ;
Carolina Carrasco ;
Sergio Alonso-Orgaz ;
José Fortes ;
Carlos Cenjor ;
Antonio López-Farré .
European Archives of Oto-Rhino-Laryngology and Head & Neck, 2005, 262 :512-516
[2]   Soluble guanylate cyclase and nitric oxide synthase in synaptosomal fractions of bovine retina [J].
Margulis, A ;
Pozdnyakov, N ;
Dang, L ;
Sitaramayya, A .
VISUAL NEUROSCIENCE, 1998, 15 (05) :867-873
[3]   Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat [J].
Zanetti, M ;
Barazzoni, R ;
Stebel, M ;
Roder, E ;
Biolo, G ;
Baralle, FE ;
Cattin, L ;
Guarnieri, G .
ATHEROSCLEROSIS, 2005, 181 (01) :69-73
[4]   Soluble Guanylate Cyclase Dysfunction and Nitric Oxide Pathway in Chronic Rhinosinusitis With Nasal Polyps: Predictive Markers for Postoperative Recurrence [J].
Jiang, Sijie ;
Zhang, Caixia ;
Tong, Zongjing ;
Xie, Shaobing ;
Xie, Zhihai ;
Zhang, Hua ;
Jiang, Weihong .
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2025, 39 (01) :63-75
[5]   Expression of nitric oxide synthase in nasal polyps [J].
Tsuyoshi Yoshimura ;
Tae Chul Moon ;
Chris St Laurent ;
Lakshmi Puttagunta ;
Erin Wright ;
A Dean Befus .
Allergy, Asthma & Clinical Immunology, 6 (Suppl 2)
[6]   Differential activity of nitric oxide synthase in human nasal mucosa and polyps [J].
Ramis, I ;
Lorente, J ;
RoselloCatafau, J ;
Quesada, P ;
Gelpi, E .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (02) :202-206
[7]   Evidence for the involvement of neuronal nitric oxide synthase and soluble guanylate cyclase on cognitive functions in rats [J].
Komsuoglu-Celikyurt, Ipek ;
Gocmez, Semil S. ;
Mutlu, Oguz ;
Gacar, Nejat ;
Aricioglu, Feyza ;
Utkan, Tijen .
LIFE SCIENCES, 2011, 89 (23-24) :905-910
[8]   Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets [J].
Medvedev, A ;
Bussygyna, O ;
Pyatakova, N ;
Glover, V ;
Severina, I .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (04) :763-766
[9]   Expression of nitric oxide synthase and guanylate cyclase in the human ciliary body and trabecular meshwork [J].
Wu Ren-yi ;
Ma Ning .
CHINESE MEDICAL JOURNAL, 2012, 125 (01) :129-133
[10]   Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts [J].
Kojda, G ;
Kottenberg, K ;
Noack, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (2-3) :181-190